OpenVSafe by OpenVAERS
Search V-safe

9JL-12406-87131

5 vaccinations 16 coded responses 65 check-ins 16 free-text entries 1 call case
Sex
Male
Age at first dose
56-60
ZIP prefix
939 / CA
Registered
2021-04-21
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-21
    Registered in v-safe
  2. 2021-04-21
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-21
    Survey response — day 0, dose 1
    MedDRA: No adverse event — Feeling: Fair · Site: Pain · Headache
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Self-medication, Vitreous floaters — Feeling: Good
    Free text: Issue with eye floater left eye subsided after taking advil
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vitreous floaters — Feeling: Good
    Free text: Still have floaters l eye, are becoming less
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-28
    Health check-in — day 7, dose 1
    Feeling: Fair · Headache
    Adult check-in
  11. 2021-05-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-12
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-12
    Health check-in — day 0, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-05-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-05-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-05-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-05-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-11-10
    Survey response — 6 months, dose 2
    MedDRA: Allergic respiratory symptom, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activities
    Free text: Minor cold and allergy symptoms for 2-4days. Tested for COVID . Negative Results.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-12-03
    Dose 3 — Pfizer-BioNTech
  29. 2021-12-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site pain, Injection site swelling — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Pain and swelling within the injection site
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-12-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site pain, Injection site swelling — Feeling: Good · Site: Pain
    Free text: Minimal swelling, pain at injection site only
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-12-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Nausea — Feeling: Fair · Nausea
    Free text: Nausea
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-12-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-12-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-12-10
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-12-17
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-12-24
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-31
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-01-07
    Survey response — day 35, dose 3
    MedDRA: Sinusitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Sinusitis with no other symptoms
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-01-14
    Survey response — day 42, dose 3
    MedDRA: Sinus disorder — Feeling: Good · Be unable to do your normal daily activities
    Free text: Sinus issues only for about a week.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-03-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-04-25
    Dose 4 — Pfizer-BioNTech
  42. 2022-04-26
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain, Swelling · Headache
    Adult check-in
  43. 2022-04-27
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  44. 2022-04-28
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  45. 2022-04-29
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  46. 2022-04-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Headache
    Adult check-in
  47. 2022-05-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Headache
    Adult check-in
  48. 2022-05-02
    Health check-in — day 7, dose 4
    Feeling: Fair · Headache
    Adult check-in
  49. 2022-05-09
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  50. 2022-05-16
    Survey response — day 21, dose 4
    MedDRA: Headache, Rhinorrhoea, Sneezing — Feeling: Good
    Free text: Running nose(nasal drip) sneezing, mild headache
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-05-23
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-05-30
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-06-06
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-07-25
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-10-25
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-11-02
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  57. 2022-11-02
    Survey response — day 0, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  58. 2022-11-03
    Health check-in — days 1–6 daily, dose 5
    Feeling: Poor · Chills, Muscle or body aches, Nausea
    Adult check-in
  59. 2022-11-04
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Fever · Headache, Muscle or body aches
    Adult check-in
  60. 2022-11-05
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Headache
    Adult check-in
  61. 2022-11-06
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  62. 2022-11-07
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Headache
    Adult check-in
  63. 2022-11-08
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Headache
    Adult check-in
  64. 2022-11-09
    Health check-in — day 7, dose 5
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  65. 2022-11-16
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  66. 2022-11-23
    Survey response — day 21, dose 5
    MedDRA: Abdominal discomfort, Dizziness, Influenza — Feeling: Good
    Free text: Low flu symptoms like unsettled stomach, and lightheaded for about 24 hours.
    MedDRA releases: 2024-11 · check-in free text available
  67. 2022-11-30
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  68. 2022-12-07
    Survey response — day 35, dose 5
    MedDRA: Chills, Influenza like illness, Office visit, Oropharyngeal pain, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Flu like, chills, runny nose, sore throat for about three days · Healthcare visit (other): Doctor visit
    MedDRA releases: 2024-11 · check-in free text available
  69. 2022-12-07
    Report sent to call center — day 35, dose 5
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  70. 2022-12-08
  71. 2022-12-09
    Call successful
    Participant prefers to complete VAERS report online
  72. 2022-12-15
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  73. 2023-02-01
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  74. 2023-05-03
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-21Pfizer-BioNTech
22021-05-12Pfizer-BioNTech
32021-12-03Pfizer-BioNTech No
42022-04-25Pfizer-BioNTech No
52022-11-02Pfizer-BioNTech Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — day 0, dose 1

2021-04-21

Systemic reaction (other): No

Release 7 — days 1–6 daily, dose 1

2021-04-22

Systemic reaction (other): None

2021-04-23

Systemic reaction (other): None

2021-04-24

Systemic reaction (other): Issue with eye floater left eye subsided after taking advil

2021-04-25

Systemic reaction (other): Still have floaters l eye, are becoming less

2021-04-26

Systemic reaction (other): None

Release 10 — 6 months, dose 2

2021-11-10

Symptoms: Minor cold and allergy symptoms for 2-4days. Tested for COVID . Negative Results.

Release 10 — days 1–6 daily, dose 3

2021-12-04

Systemic reaction (other): Pain and swelling within the injection site

2021-12-05

Systemic reaction (other): Minimal swelling, pain at injection site only

2021-12-06

Systemic reaction (other): Nausea

Release 10 — day 35, dose 3

2022-01-07

Symptoms: Sinusitis with no other symptoms

Release 10 — day 42, dose 3

2022-01-14

Symptoms: Sinus issues only for about a week.

Release 11 — day 21, dose 4

2022-05-16

Symptoms: Running nose(nasal drip) sneezing, mild headache

Release 12 — day 0, dose 5

2022-11-02

Release 12 — day 21, dose 5

2022-11-23

Symptoms: Low flu symptoms like unsettled stomach, and lightheaded for about 24 hours.

Release 12 — day 35, dose 5

2022-12-07

Symptoms: Flu like, chills, runny nose, sore throat for about three days
Healthcare visit (other): Doctor visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDAbdominal discomfort · · ✓
SDAllergic respiratory symptom · · ✓
SDChills · · ✓
SDDizziness · · ✓
SDHeadache · · ✓
SDInfluenza · · ✓
SDInfluenza like illness · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSinus disorder · · ✓
SDSinusitis · · ✓
SDSneezing · · ✓
SROInjection site pain · · ✓
SROInjection site swelling · · ✓
SRONausea · · ✓
SRONo adverse event ✓ ✓ ✓
SROSelf-medication ✓ ✓ ✓
SROVitreous floaters ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release